Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation | Zendy

Y Dündar | Zendy; A Bagust | Zendy; Rumona Dickson | Zendy; Susanna Dodd | Zendy; J Green | Zendy; A Haycox | Zendy; Ruaraidh Hill | Zendy; C McLeod | Zendy; T Walley | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation

Author(s) -

Y Dündar,

A Bagust,

Rumona Dickson,

Susanna Dodd,

J Green,

A Haycox,

Ruaraidh Hill,

C McLeod,

T Walley

Publication year - 2007

Publication title -

health technology assessment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.426

H-Index - 126

eISSN - 2046-4924

pISSN - 1366-5278

DOI - 10.3310/hta11010

Subject(s) - medicine , pemetrexed , psychological intervention , intensive care medicine , health care , mesothelioma , quality of life (healthcare) , economic evaluation , rehabilitation , physical therapy , nursing , surgery , pathology , chemotherapy , cisplatin , economics , economic growth

To assess the clinical effectiveness and cost-effectiveness of pemetrexed disodium in combination with cisplatin for the treatment of unresectable pleural mesothelioma in chemotherapy-naive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research